Dynamic Neural Systems Underlying Social-emotional Functions in Older Adults
Dynamo
3 other identifiers
interventional
75
1 country
1
Brief Summary
Assess the impact of a remote, app-delivered digital meditation intervention on emotional well-being of lonely older adults. Neuroimaging, electrophysiological (EEG), and autonomic physiology will be used to assess the neural correlates of the intervention. EEG and autonomic physiology will be collected while participants watch 30 min of an awe-inspiring movie. fMRI and autonomic physiology will be collected in the context of a social exploration/exploitation task.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 28, 2022
CompletedFirst Posted
Study publicly available on registry
December 12, 2022
CompletedStudy Start
First participant enrolled
October 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedDecember 24, 2025
December 1, 2025
2.2 years
November 28, 2022
December 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in the WHO-5 Well-Being Index
WHO-5 ranges from 0-25, with higher values indicating higher well-being
Change in well-being from baseline to directly after completing the intervention (6 weeks)
Secondary Outcomes (4)
Change in the 20-item UCLA loneliness scale
Change in loneliness from baseline to directly after completing the intervention (6 weeks)
Change in the General Anxiety Disorder-7 (GAD-7)
Change in anxiety from baseline to directly after completing the intervention (6 weeks)
Change in Psychological Stress Measure (PSM-9)
Change in stress from baseline to directly after completing the intervention (6 weeks)
Change in Patient Health Questionnaire (PHQ-9)
Change in depression from baseline to directly after completing the intervention (6 weeks)
Study Arms (3)
intervention
EXPERIMENTALParticipants will engage with the digital meditation app delivering the intervention 15 min a day, five days, a week for 6 weeks.
waitlist control
ACTIVE COMPARATORParticipants will be randomized to a waitlist group for six weeks. The waitlist control group will then be able to use the meditation app for six weeks as the primary intervention group
Baseline physiology
OTHERA subset of participants will not participate in the intervention. Only baseline fMRI and EEG data will be collected in these participants.
Interventions
the digital meditation app will be installed on participants iPad or android. Lonely older adults will use the app five days a week for six weeks total. Neuroimaging will be performed before and after the intervention.
Participants in the waitlist group will have to wait six weeks after being screened before being able to use the meditation app after the assessment of primary and secondary endpoints
Eligibility Criteria
You may qualify if:
- years of age or older
- English language fluency
- Naive to meditation practices (not actively meditating more than one hour per month and/or meditation practice for less than a year in their entire life-time)
- No MRI contra-indications
- Cognitively healthy (no diagnosis of dementia, stroke, developmental disorders, or major systemic diseases that may impact cognitive function)
You may not qualify if:
- Below 60 years of age
- Not fluent in English
- Active meditator (meditating more than one hour per month and/or meditation practice for more than a year in their entire life-time).
- Presence of a severe psychiatric (e.g. schizophrenia, bipolar disorder, PTSD), neurological (epilepsy, traumatic brain injury, dementia, multiple sclerosis), or developmental disorder (e.g. autism)
- Systemic disease (e.g. major recent surgeries, cancer)
- Claustrophobia
- Contraindications for MR safety (e.g. metal in body, cochlea implants)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California San Francisco
San Francisco, California, 94158, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lorenzo Pasquini, PhD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2022
First Posted
December 12, 2022
Study Start
October 13, 2023
Primary Completion
December 28, 2025
Study Completion (Estimated)
July 1, 2026
Last Updated
December 24, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share